Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: Guidance for clinicians to prevent coronary heart disease

B.G. Nørdestgaard, M.J. Chapman, S.E. Humphries, H.N. Ginsberg, L.L. Masana, O.S. Descamps, O. Wiklund, R.A. Hegele, F.J. Raal, J.C. Defesche, A. Wiegman, R.D.D. Santos, Gerald Watts, K.G. Parhofer, G.K. Hovingh, P.T. Kovanen, C.R. Boileau, M.R. Averna, J. Borén, E. BruckertA.L. Catapano, J.A. Kuivenhoven, P.E. Pajukanta, K.K. Ray, A.F.H. Stalenhoef, E.S.G. Stroes, M.R. Taskinen, A. Tybjærg-Hansen

Research output: Contribution to journalArticle

1449 Citations (Scopus)

Abstract

Aims The first aim was to critically evaluate the extent to which familial hypercholesterolaemia (FH) is underdiagnosed and undertreated. The second aim was to provide guidance for screening and treatment of FH, in order to prevent coronary heart disease (CHD). Methods and results Of the theoretical estimated prevalence of 1/500 for heterozygous FH,
Original languageEnglish
Pages (from-to)3478-3490a
JournalEuropean Heart Journal
Volume34
Issue number45
DOIs
Publication statusPublished - 2013

Fingerprint

Dive into the research topics of 'Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: Guidance for clinicians to prevent coronary heart disease'. Together they form a unique fingerprint.

Cite this